William R. Jarnagin, MD, FACS

Chief, Hepatopancreatobiliary Service; Benno C. Schmidt Chair in Surgical Oncology
Pictured: William Jarnagin

William Jarnagin – a surgeon who treats patients with disorders of the pancreas, liver, and bile ducts – discusses the specialized expertise of surgeons at Memorial Sloan Kettering, a high-volume center.


I am a surgeon with more than 15 years of experience in diagnosing and treating men and women with benign and malignant (cancerous) diseases of the liver, bile ducts, gallbladder, and pancreas. Most of my patients have primary liver cancer, pancreatic cancer, bile duct cancer, or colon cancer that has spread (metastasized) to the liver, which is known as secondary liver cancer. I also treat benign conditions such as pancreatic cysts.

As Chief of Memorial Sloan Kettering’s Hepatopancreatobiliary Service, I oversee a team of seven board-certified surgeons that performs as many as 1,000 cancer-related operations every year on the liver, pancreas, gallbladder, and bile ducts. We work intimately with the broader healthcare group — medical oncologists, radiologists, and others — meeting weekly to discuss each patient’s care. In these and other ways, we design the very best treatment plan possible, customized to each individual’s needs.

Appointments for New Patients
Clinical Expertise

General Surgical Oncology; Benign and Malignant Disease of the Liver, Bile Ducts and Gallbladder; Pancreatic Cancer

Languages Spoken

MD, Rush Medical College


University of California at San Francisco


Memorial Sloan Kettering Cancer Center; San Francisco General Hospital, University of California at San Francisco

Board Certifications


Publications by William R. Jarnagin
Visit PubMed for full listing of William R. Jarnagin journal articles
Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.